|
|
| A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. LY317615 blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent. Also called enzastaurin and enzastaurin hydrochloride. |
Previous Definitions: | luteinizing hormone-releasing hormone, lutetium texaphyrin, Luvox, LY231514, LY293111 | Next Definitions: | LY335979, LY353381 hydrochloride, lycopene, lymph, lymph gland |
|
|